SCHEMBL29695022

SCHEMBL29695022

CSc1ccc(COc2nnc(N)s2)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MBOAT4 Q96T53 1/20 0.41
▸ PIK3CD O00329 1/20 0.34
▸ PIK3CA P42336 1/20 0.34
▸ PIK3CB P42338 1/20 0.34
▸ PI4KA P42356 1/20 0.34
▸ PI4KB Q9UBF8 1/20 0.34
▸ RAB9A P51151 5/20 0.33
▸ POLB P06746 3/20 0.32
▸ MAPT P10636 3/20 0.32
▸ HPGD P15428 2/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ SMN1; SMN2 Q16637 4/20 0.32
▸ NPC1 O15118 3/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ LMNA P02545 2/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ FBP1 P09467 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29108359 1.00 MBOAT4 (0.41) MBOAT4PIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL24500409 0.81 MGAM (0.40) RAB9APOLBMAPTHPGDALDH1A1
SCHEMBL22717489 0.81 ALDH1A1 (0.43) PIK3CDPIK3CAPIK3CBPI4KAPI4KB
SCHEMBL29108351 0.79 ALDH1A1 (0.46) MBOAT4PIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL29695046 0.79 ALDH1A1 (0.46) MBOAT4PIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL22717648 0.78 RAB9A (0.43) MBOAT4PIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL22717514 0.78 MEN1 (0.41) MBOAT4PIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL29108503 0.77 TSHR (0.43) PIK3CDPIK3CAPIK3CBPI4KAPI4KB
SCHEMBL29108435 0.76 PIK3CA (0.36) PIK3CDPIK3CAPIK3CBPI4KAPI4KB
SCHEMBL24501336 0.76 RAB9A (0.35) MBOAT4PIK3CDPIK3CAPIK3CBPI4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250325552-A1 SUBSTITUTED THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES INC (US) 2025-10-23 — — US disclosed
CN-117083271-A Substituted thiadiazolyl derivatives as DNA polymerase theta inhibitors 伊迪亚生物科学有限公司 2023-11-17 — — CN disclosed
EP-4255573-A1 SUBSTITUTED THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS Ideaya Biosciences, Inc. (US) 2023-10-11 — — EP disclosed
WO-2022118210-A1 SUBSTITUTED THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES, INC. (US) 2022-06-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250325552-A1 SUBSTITUTED THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS POLQ, POLK, POLH MBOAT4 4171/4885PIK3CD 127/4885PIK3CA 198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback